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Abstract. Metabolic epidermal necrosis (MEN) was diagnosed in an unspayed nine-year-old 
male Poodle, associated with interface hepatitis and with active chronic pancreatitis. Also, a tumour 
formation was noticed at the cranial pole of the right kidney, both in ultrasound and in laparotomy 
examination. The histopathology did not establish the type of tumour, due to a human error. It is the 
first case of MEN in dogs recorded in Romania.  
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INTRODUCTION 
 
Metabolic epidermal necrosis (MEN) is a term used to describe an erosive crusting 
dermatopathy with a characteristic topographical distribution. The terms superficial necrolytic 
dermatitis, necrolytic migratory erythema, glucagonoma syndrome, and hepatocutaneous 
syndrome have also been used in humans and animals. In animals it has most frequently been 
reported in the dog (Byrne 1999) but has also been reported in cats (Patel and others 1996, 
Kimmel and others 2003) and in Black Rhinoceroses (Munson and others 1998). In dogs the 
disease was described for the first time in 1986 in four animals with diabetes for which it was 
named diabetic dermatopathy (Walton and others1986). 
In humans approximately 90% of the cases with necrolytic migratory erythema is most 
often associated with a glucagon-secreting pancreatic α-cell neoplasm (Bloom and Polak 1987, 
Mark 2001, Pujol and others 2004) and on rare occasions with chronic pancreatitis, 
micronodular hepatic cirrhosis, chronic disease of intestine, several malabsorption syndromes, 
malfunction of zinc and essential fatty acids metabolism and myelodysplastic syndrome 
(Marinkovich and others 1995, Technau and others 2005). In contrast to people, most cases of 
MEN in dogs were accompanied by hepatopathy (Gross and others1993, Cadiergues and 
others 2000, Koutinas and others 2002, Outerbridge and others 2002, Waner and others 2007) 
and some with glucagonomas (Gross and others 1990, Miller and others 1991, Torres and 
others 1997, Alenspach and others 2000, Cave and others 2008) and diabetes mellitus 
(Walton and others 1986, Gross and others 1990, Gross and others 1993, Koutinas and others 
2002,). 
Byrne (1999) proposed a classification scheme for MEN in dogs: MEN with a 
pancreatic neoplasm on histopathology (MEN-GS), MEN without a pancreatic neoplasm on 
histopathology (MEN-HS), and MEN where no conclusive cause was determined (MEN-ND). 
The pathogenesis of this dermatopathy, in dogs and in people is unknown (Turek 2003). It has 
been suggested that because glucagon results in sustained gluconeogenesis and is involved in 
the catabolism of amino acids, chronic elevation of the hormone, as seen in association with 
glucagonomas, may be the direct cause of hypoaminoacidaemia, which may lead to epidermal 
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protein depletion and subsequent keratinocyte necrolysis (Boden and others 1984, Gross and 
others 1990, Kasper and McMurry 1991, Miller and others 1991, Gross and others 1993, 
Torres and others 1997, Byrne 1999). This hypothesis is supported by the rapid 
dermatological improvement that is seen in people (and one dog) (Torres and others 1997) 
after surgical resection of the tumour or with glucagoninhibiting somatostatin analogue 
treatment (Kasper 1992), as well as by the temporary resolution of skin lesions in people after 
intravenous infusion of amino acids (Cave and others 2008). 
Hepatic impairment has also been implicated as a possible mechanism (Miller and 
others 1990). Intuitively, this seems a reasonable theory in light of the more frequent 
association of MEN with hepatopathy than pancreatic neoplasia in the dog. Interestingly, 
many, although not all, canine and human patients with hepatopathy related MEN also have 
elevated serum glucagon levels (Gross and others 1993, Bond and others 1995). This may 
further support the implication of liver impairment in the pathogenesis of the condition, 
perhaps by way of decreased metabolism of glucagons (Miller and others 1991). 
 
CASE REPORT 
 
History 
A nine-year-old unspayed male Poodle was presented with a history of lethargy, 
weakness, polydipsia, polyuria and with extensive cutaneous lesions that started two months 
ago. The reason of presenting for consulting were the cutaneous lesions as the owner did not 
consider the change in the general state of the dog as a reason to be worried. The dog was 
treated with cephalexin (Ceporex; Schering-Plough Animal Health) 10mg/kg i.m. per day, for 
2 weeks and topically with 2% clorhexidine shampoo (Ado Clorhexidina; LabCalier Sp) 
every second day, for 4 weeks. There was no improvement of the cutaneous lesions. 
 
Clinical examination  
The patient presented a mediocre body condition, decreased appetite, apathy, 
hypothermia (37,4o C), normal cardiac and respiratory frequency, pale mucosa, and capillary 
refill time of 2-3 seconds. Prescapular and popliteal lymph nodes were easily increased in 
volume, smooth and not painful. Slight abdominal ptosis and hepatomegaly on palpation was 
noticed. While handling the animal, he was aggressive due to the pain given by the gravity of 
the lesions. 
On the scrotal and preputial regions, inguinal and internal side of thighs, perianal zone 
and ventral side of the tail, erythema, erosions and ulcers were revealed (Fig 1). Furthermore, 
on the carpal, metacarpal and phalangeal regions (Fig 2), and elbow articulations diffuse 
alopecia, erosions, ulceration and adherent crusts were noticed. Multiple onychogryphosis, 
perionixis and foot pads hyperkeratosis were identified on limbs (Fig 3). The nose presented 
moderate hyperkeratosis, accompanied by fissuring.  
Hepatomegaly correlated with the type and disposition of cutaneous lesions led us to 
suspect hepatocutaneous syndrome. To confirm this supposition there where applied 
complementary tests: cutaneous cytological examination; haematological and biochemical 
tests; excisional biopsy from lower abdominal region; abdominal ultrasound and exploratory 
laparotomy. 
 
Complementary examination 
On cutaneous cytological examination numerous neutrophils and lymphocytes were 
noticed along with polymorph bacterial flora, free and phagocytated fungal cells (Candida 
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spp.). Haematological examination revealed microcytic/hypochromic anemia, leukocytosis, 
neutrophilia, lymphopenia and target cells (Table 1). Serum alkaline phosphatase (ALP) and 
natremy were increased, 61 times, respectively 1.3 times. Glycemia and cholesterol had 
normal values (Table 2).  
 
Tab. 1 
Hematological parameters 
 
Parameter Value  Expected range 
RBC 5.5 X103/µL 5.5 -8.5 X103/µL 
Hg 8.7 g/dL 12-19 g/dL 
HCT 32% 37-54% 
MCV 58.18 fL 60-93 fL 
MCH 27.18% 30-45% 
MCHC 15.81 pg 20-25 pg 
WBC 21200 /mL 6000-13000/mL 
Neutrophile 82% 57-77% 
Eosinophile 4% 2-10% 
Basophile 0 Rare 
Lymphocyte 8% 17-40% 
Monocyte 6% 1-10% 
 
Tab. 2 
Biochemical parameters 
 
Parameter Value Expected range 
GLU 86 mg/dL 63-100 mg/dL 
CHOL 127 mg/dL 90,3-306,9 mg/dL 
ALP 8590 u/L 30-140 u/L 
ALT 84 u/L < 40 u/L 
Na+ 204 mmol/L 135-155 mmol/L 
K+ 3,1 mmol/L 3,5-5,5 mmol/L 
 
Cutaneous histopathology (haematoxylin and eosin staining) showed superficial 
perivascular hyperplastic dermatitis. The lesions on the epidermic level were represented by 
serocellular crusting, superficial/infundibular parakeratosic hyperkeratosis, “epidermal palor” 
(intracellular oedema in the spinous layer and spongiosis), vesicle with serous content, 
intracorneous pustule and moderate basal cell hyperplasia. The lesions had a red/white/blue 
appearance. On superficial derma, there was perivasculitis with mild infiltrate of neutrophils, 
lymphocytes and macrophages, moderate oedema and pigmentary incontinence (Fig 4).  
Abdominal ultrasound revealed a heteroechogenic aspect of the liver, with multiple 
hypoechogenic nodes giving the aspect of “honey comb”. The cranial pole of the right kidney 
was covered about 1/3 by a hypoechogenic oval formation with heterogenous echostructure. 
The size of the formation was 48mm/46mm and presented distinctive limits (Fig 5).  
On exploratory laparotomy nodular hyperplasia of the pancreas was shown. The liver 
showed a firm consistence and bosselated aspect given by numerous red-brown or yellow-
brown nodes and interlobular parenchymal collapse (Fig 6). At the cranial pole of the right 
kidney there was a tumor like formation, dark-red in colour, marble like aspect, evident 
vascularisation and three times larger than the kidney (Fig 7). Because the patient died during 
this particular intervention, we harvested fragments of liver, pancreatic and tumor formation 
tissues. Due to a technical error the histopathological examination of the tumor like formation 
was not done. Histopathological examination of the pancreas revealed zones with perilobular 
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necrosis of the exocrine acini with cellular infiltrate dominated by granulocytes. In these 
zones the intralobular pancreatic channels showed epithelium vacuolisation. At the edge of 
some lobes, fibrosis zones were noticed, that included acini debris, adipocyte and 
plasmocitary infiltrate in the interstitial spaces. The established histopathological diagnose 
was active chronic pancreatitis.  
The histopathological examination of the liver revealed: 1) bile accumulation in biliary 
ducts forming brown-green “biliary thrombi”; 2) micro-and macrovacuolary perilobular 
degeneration, some perilobular hepatocytes with foamy cytoplasm and biliary pigments – 
“feathery degeneration”; 3) hypertrophy and hyperplasia of Kupffer cell, and their charging 
with biliary pigments; 4) coagulation necrosis of perilobular hepatocytes with the destruction 
of the limiting plate – “piecemeal necrosis”; 5) necrosis of the epithelium of the small biliary 
ducts; 6) presence of biliary pigments in macrophages with foamy cytoplasm in the portal 
tract; 7) infiltrate with neutrophils in the portal tract; 8) hepatic dysplasia with huge cells 
translated with atypical, large, hepatic cells with nuclear polymorphism and anisocoria, 
hyperchromia and multinuclear cells with a normal nuclear-cytoplasmic ratio and without 
deforming the architecture of the surrounding parenchyma and 9) focal extramedullar 
hematopoiesis translated with the appearance of megacariocytes. Based on the described 
lesions, the established histopathological diagnose was interface necrotic hepatitis due biliary 
stasis.  
 
 
 
 
 
 
 
 
 
Fig. 1. Erythema and erosions on the inguinal, 
preputial and scrotal regions. The site of skin 
biopsy is indicated by the ellips 
Fig. 2. Alopoecia, erythema, erosions, ulcers on 
metacarpal and digits regions and multiple 
onychogryphosis 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Hyperkeratosis and fissuring of footpads. Fig. 4. Superficial necrolytic dermatitis in a dog. 
H&E. Bar = 100 µm. 
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Fig. 5. Kidney ultrasound. Note the presence of a 
hypoechogenic oval formation with heterogenous 
echostructure to the cranial pole of the right kidney, 
48/46 mm in size. 
Fig. 6. Laparotomy. Liver with a firm consistence and 
bosselated aspect given by numerous red-brown or 
yellow-brown nodes and interlobular parenchymal 
collapse. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Laparotomy. A tumor like formation, dark-red in colour, marble like aspect, with evident vascularisation 
and three times larger than the kidney. The tumor like formation is located to the cranial pole of the right kidney. 
 
DISCUSSION 
 
MEN is a multifactorial metabolic disease with unknown etiopathogenesis. The 
incidence of this disease in dogs is low, approximately 0.3% (Miller and others 1990). The 
disease is presented mostly in older dogs, especially in males around 10-years-old from small 
breeds (Cadiergues and others 2000, Scott and others 2001, Koutinas and others 2002, 
Outerbridge and others 2002, Guaguére and others 2006). 
Even though our patient had an affected general state (weakness, lethargy, polydipsia, 
polyuria), for the owner these changes were not a reason of concern, and the reason of the 
examination were severe cutaneous lesions. The recorded macroscopical cutaneous lesions 
and their topography were similar with those reported by other authors. These were 
represented by alopecia, erythema, erosions, ulcers and crusts with perioral, muzzle, 
periocular, anogenital localisation, on pressure points, distal extremity of limbs and on the 
thorax. The footpads hyperkeratosis with or without fissuring or ulceration is described in 
over 90% of the cases, and is considered a suggestive lesion in establishing the diagnosis 
(Scott and others 2001, Koutinas and others 2002, Outerbridge and others 2002, Guaguére 
and others 2006). 
These lesions, especially those located on the head, on the genital region, on the distal 
extremity of the limb and to the footpads are present in other diseases like: pemphigus 
foliaceus, systemic lupus erythematosus, toxic epidermal necrolysis, and dermatitis due to 
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zinc deficiency and erythema multiforme, but the histopathological cutaneous lesions allow 
the diagnosis of MEN.  
Secondary cutaneous infections with bacteria, fungus or dermatophyte are frequently 
reported in cases with MEN (Byrne 1999, Scott and others 2001, Koutinas and others 2002, 
Guaguére and others 2006). In our case a mixed infection with bacteria and Candida fungus 
was present. The reaction of the prescapular and popliteus lymph nodes as well as the 
lymphocytosis with neutrophilia were attributed to this infection.  
The hematological and biochemical modification were reported frequently on dogs with MEN, 
such as aregenerative anemia, poikilocytosis, target cells, neutrophilia, hypoalbuminemia, 
beta and gamma globulin increased level and a significant increase of hepatic enzyme activity 
(Scott and others 2001, Koutinas and others 2002, Guaguére and others 2006). In our case 
there was hypochromic microcytic anemia. The same type of anemia was described by other 
authors (Cadiergues and others 2000, Waner and others 2007).  
In a dog with MEN associated with pancreatic adenocarcinoma, a state of 
normochromic microcytic anemia was identified (Cave and others 2008). Koutinas and others 
(2002) reported aregenerative normochromic, normocytic anemia. The anemia could be 
caused by chronic inflammation associated to this disease (Couto 1998). The presence of 
target cells is frequently reported in hepatobiliary diseases accompanied by biliary stasis and 
in hypothyroidism. This particular aspect of red blood cells is reported in our case as well. It 
is caused by cholesterol and phospholipids accumulation in the red blood cell membrane or, 
less frequently by the decrease of the hemoglobin concentration, as a result of an iron 
metabolism alteration in liver failure. 
In dogs with MEN associated with glucagonomas there is usually hypoglycemia, 
especialy in terminal cases associated with diabetes. In our case, as in other reports 
(Cadiergues and others 2000, Koutinas and others 2002, Cave and others 2008), the glycemia 
had normal values, while the dog presented polydipsia and polyuria. The most plausible cause 
of normal glycemia is given by Cave et al who consider that this is happening due to the 
duality between glucagon and insulin hyperproduction, aspect reported in a dog with 
pancreatic adenocarcinoma (Cave and others 2008). These authors suggest the possibility of a 
homeostatic response to the paraneoplasic superproduction of a single hormone (glucagon or 
insulin). This theory is sustained by McNeil (1998), who underlines that the absence of 
macroscopical and microscopical lesions from pancreatic level cannot exclude the possibility 
of evolution of secretory glucagonomas. The diagnosis of this affection can be established 
only through immunohistochemistry.  
Moderate increases of serum activity of alanine aminotransferase and of alkaline 
phosphatase are humoral modifications, reported constantly in dogs diagnosed with MEN 
(Gross and others 1990, McEwen 1994, Cadiergues and others 2000, Waner and others 2007). 
In the case described here, ALAT registered a double value (84U/l) as normal and alkaline 
phosphatase (8590 U/l) was approximately 60 times higher than the maximum normal level 
(140 U/l). From the literature we consulted (Gross and others 1993, McEwen 1994, 
Outerbridge and others 2002, Waner and others 2007, Cave and others 2008) it seems that this 
is the highest value reported until now. The significant increasing of seric PAL is registred in 
dogs with biliary stasis and those with hyperadrenocortical syndrome. The difference between 
primary and secondary hepatopathy of hyperadrenocortical syndrome cannot be determined 
only by testing the liver functions (Feldman 2000). 
Polyuria and polydipsia, hypernatremia and hypokalemia with marking increase of 
alkaline phosphatase reported in this case should be the hint of cortical suprarenal tumor 
(Taylor 2000). The ultrasound aspect of the formation from the cranial pole proximity of the 
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right kidney and its visualisation during the exploratory laparotomy sustain the hypothesis of 
suprarenal tumor. Along with the implication of biliary stasis in the increase of ALP, an 
important component of its value could be given to the suprarenal tumor as well. 
Unfortunately a human error did not permit a sure identification of the neoplasic formation.  
The “honey comb” aspect shown in the liver is due to the presence of hypoechogenic zones 
joined together and limited on the edges by intense echographic halo. Hypoechogenic zones 
correspond histopathologicaly to some regenerating focus and the hyperechogenic layout 
suggests that stromas condense in the parenchymal collapse internodular zones. Even though 
the presence of regenerating focuses suggest, according to some authors (McNeil 1998) 
modifications like micronodular cirrhosis, in our case the histopathological examination did 
not show any fibrous proliferation. For this reason most authors (Jacobson and others 1995, 
Nyland and others 1996) agreed that this particularly “honey comb” or “Swiss cheese” image 
obtained from liver ultrasound in dogs can be associated exclusively to MEN.  
Scott et al reported that, from the 75 cases of MEN, in only five the associated 
condition with pancreatic tumors was shown, in the rest hepatic conditions were present. 
Recently there was one more case reported with pancreatic adenocarcinoma associated with 
hyperglucagonemia, hyperinsulinemia and hypoaminoacidemia (Scott and others 2001, Cave 
and others 2008). In our case MEN is associated with necrotic hepatitis with biliary stasis 
interface, active chronic pancreatitis and probably with a tumor of suprarenal gland.  
The survival rate of dogs with MEN from the moment of diagnose is a few months (Miller 
and others 1990, Outerbridge and others 2002). The fact that our patient did not survive the 
exploratory laparotomy, together with the hypothermic state, shows that the disease was in a 
very advanced state.  
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